560 related articles for article (PubMed ID: 18835753)
1. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
3. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
4. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
5. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
6. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
8. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
10. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis.
Kappler M; Kraxner A; Reinhardt D; Ganster B; Griese M; Lang T
Thorax; 2006 Aug; 61(8):684-8. PubMed ID: 16449259
[TBL] [Abstract][Full Text] [Related]
13. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
[TBL] [Abstract][Full Text] [Related]
14. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
15. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
[TBL] [Abstract][Full Text] [Related]
16. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
[TBL] [Abstract][Full Text] [Related]
19. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
